Device Helps Stroke Victims with Foot Drop

Patients who suffered a stroke that resulted in partial leg paralysis causing foot drop who are treated at the Weill Cornell Medical Center are the first people eligible to receive a new rehabilitation device. The NESS L300, manufactured by Bioness, Inc., recently gained approval from the FDA.

The NESS L300 is a lightweight neuro-rehabilitation device used in both the in- and out-patient settings. The device is worn in lieu of a traditional foot brace and stimulates the peroneal nerve, which activates the calf muscle to correct the foot drop. The nerve is stimulated with painless electrical stimulation after sensors detect whether the foot is properly positioned.

Studies with the device indicate functional improvements; including improved walking coordination, speed, and blood flow. The device also minimizes the amount of effort required for ambulation.

Hospital Buyer

News for healthcare procurement decision makers